Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
4.950
-0.120 (-2.37%)
At close: Dec 20, 2024, 4:00 PM
4.990
+0.040 (0.81%)
After-hours: Dec 20, 2024, 5:47 PM EST
Sagimet Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 77.01 | 75.14 | 0.16 | 56.73 | 68.7 | 10.21 |
Short-Term Investments | 75.47 | 19.76 | 32.19 | - | - | - |
Cash & Short-Term Investments | 152.49 | 94.9 | 32.35 | 56.73 | 68.7 | 10.21 |
Cash Growth | 49.73% | 193.39% | -42.99% | -17.42% | 572.76% | - |
Prepaid Expenses | 4.3 | 1.35 | 0.41 | 0.42 | - | 0.55 |
Other Current Assets | 0.41 | 0.4 | 0.03 | 1.51 | 0.04 | 0.06 |
Total Current Assets | 157.19 | 96.65 | 32.79 | 58.66 | 68.74 | 10.82 |
Property, Plant & Equipment | 0.11 | 0.07 | 0.21 | 0.34 | 0.19 | 0.32 |
Other Long-Term Assets | - | - | 0.03 | 0.03 | 0.03 | 0.03 |
Accounts Payable | 1.15 | 0.19 | 1.13 | 0.76 | 0.51 | 1.2 |
Accrued Expenses | 2.81 | 4.85 | 3.96 | 1.32 | 1.01 | 0.75 |
Current Portion of Leases | 0.12 | 0.07 | 0.13 | 0.12 | 0.15 | 0.13 |
Other Current Liabilities | 0.01 | 0.56 | 0.06 | 0.24 | 0.24 | - |
Total Current Liabilities | 4.09 | 5.65 | 5.28 | 2.44 | 1.91 | 2.08 |
Long-Term Leases | - | - | 0.08 | 0.22 | 0.07 | 0.21 |
Other Long-Term Liabilities | - | - | 0 | - | - | - |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 449.35 | 340.78 | 35 | 33.11 | 31.02 | 30.24 |
Retained Earnings | -279.11 | -249.74 | -221.87 | -191.37 | -166.93 | -155.56 |
Comprehensive Income & Other | 0.44 | 0.03 | -0.08 | - | - | - |
Total Common Equity | 170.68 | 91.07 | -186.95 | -158.26 | -135.91 | -125.32 |
Total Liabilities & Equity | 174.78 | 96.72 | 33.03 | 59.03 | 68.96 | 11.16 |
Total Debt | 0.12 | 0.07 | 0.21 | 0.35 | 0.21 | 0.34 |
Net Cash (Debt) | 169.84 | 94.83 | 32.13 | 56.38 | 68.49 | 9.87 |
Net Cash Growth | 66.94% | 195.11% | -43.01% | -17.68% | 593.87% | - |
Net Cash Per Share | 5.83 | 9.07 | 174.06 | 459.97 | 709.34 | - |
Filing Date Shares Outstanding | 32.2 | 31.91 | 22.9 | 0.12 | 0.1 | - |
Total Common Shares Outstanding | 32.2 | 22.9 | 0.19 | 0.12 | 0.1 | - |
Working Capital | 153.1 | 90.99 | 27.51 | 56.22 | 66.83 | 8.74 |
Book Value Per Share | 5.30 | 3.98 | -1010.08 | -1291.08 | -1407.55 | - |
Tangible Book Value | 170.68 | 91.07 | -186.95 | -158.26 | -135.91 | -125.32 |
Tangible Book Value Per Share | 5.30 | 3.98 | -1010.08 | -1291.08 | -1407.55 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.